GMEDGLOBUS MEDICAL INC

NYSE globusmedical.com


$ 67.15 $ 0.65 (0.98 %)    

Wednesday, 22-May-2024 15:59:55 EDT
QQQ $ 454.82 $ -0.09 (-0.02 %)
DIA $ 398.57 $ -2.12 (-0.53 %)
SPY $ 530.36 $ -1.53 (-0.29 %)
TLT $ 91.26 $ 0.11 (0.12 %)
GLD $ 225.37 $ -4.12 (-1.84 %)
$ 67.15
$ 66.35
$ 67.14 x 194
$ 70.00 x 200
$ 66.35 - $ 67.36
$ 43.39 - $ 67.37
959,877
na
9.09B
$ 1.01
$ 136.42
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-Q
2 02-21-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 02-21-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 02-17-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-04-2021 06-30-2021 10-Q
13 05-04-2021 03-31-2021 10-Q
14 02-17-2021 12-31-2020 10-K
15 10-28-2020 09-30-2020 10-Q
16 08-05-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 02-20-2020 12-31-2019 10-K
19 11-06-2019 09-30-2019 10-Q
20 08-01-2019 06-30-2019 10-Q
21 05-02-2019 03-31-2019 10-Q
22 02-21-2019 12-31-2018 10-K
23 11-08-2018 09-30-2018 10-Q
24 08-02-2018 06-30-2018 10-Q
25 05-03-2018 03-31-2018 10-Q
26 02-22-2018 12-31-2017 10-K
27 11-09-2017 09-30-2017 10-Q
28 08-03-2017 06-30-2017 10-Q
29 05-04-2017 03-31-2017 10-Q
30 03-16-2017 12-31-2016 10-K
31 11-09-2016 09-30-2016 10-Q
32 07-27-2016 06-30-2016 10-Q
33 05-04-2016 03-31-2016 10-Q
34 02-29-2016 12-31-2015 10-K
35 11-04-2015 09-30-2015 10-Q
36 07-31-2015 06-30-2015 10-Q
37 05-05-2015 03-31-2015 10-Q
38 02-26-2015 12-31-2014 10-K
39 10-31-2014 09-30-2014 10-Q
40 08-06-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 piper-sandler-upgrades-globus-medical-to-overweight-raises-price-target-to-80

Piper Sandler analyst Matt O'Brien upgrades Globus Medical (NYSE:GMED) from Neutral to Overweight and raises the price t...

 barclays-maintains-overweight-on-globus-medical-raises-price-target-to-85

Barclays analyst Matt Miksic maintains Globus Medical (NYSE:GMED) with a Overweight and raises the price target from $83 to ...

 globus-medical-shares-race-higher-after-better-than-expected-q1-results

Globus Medical reported quarterly earnings of 72 cents per share which beat the analyst consensus estimate of 57 cents by 26.32...

 btig-maintains-buy-on-globus-medical-raises-price-target-to-63

BTIG analyst Ryan Zimmerman maintains Globus Medical (NYSE:GMED) with a Buy and raises the price target from $60 to $63.

 piper-sandler-maintains-neutral-on-globus-medical-raises-price-target-to-60

Piper Sandler analyst Matt O'Brien maintains Globus Medical (NYSE:GMED) with a Neutral and raises the price target from ...

 stifel-maintains-buy-on-globus-medical-raises-price-target-to-70

Stifel analyst Mathew Blackman maintains Globus Medical (NYSE:GMED) with a Buy and raises the price target from $64 to $70.

 needham-reiterates-hold-on-globus-medical

Needham analyst David Saxon reiterates Globus Medical (NYSE:GMED) with a Hold.

 globus-medical-revises-fy24-eps-from-268-270-to-275-285-vs-269-est-revenue-from-245b-2475b-to-246b-2485b-vs-246b-est

2024 Annual GuidanceThe Company today updated its guidance for full year 2024 revenue in the range of $2.460 to $2.485 billion,...

 globus-medical-q1-eps-072-beats-057-estimate-sales-60667m-beat-58714m-estimate

Globus Medical (NYSE:GMED) reported quarterly earnings of $0.72 per share which beat the analyst consensus estimate of $0.57 by...

 btig-upgrades-globus-medical-to-buy-announces-60-price-target

BTIG analyst Ryan Zimmerman upgrades Globus Medical (NYSE:GMED) from Neutral to Buy and announces $60 price target.

 canaccord-genuity-reiterates-buy-on-globus-medical-maintains-79-price-target

Canaccord Genuity analyst Caitlin Cronin reiterates Globus Medical (NYSE:GMED) with a Buy and maintains $79 price target.

 globus-medical-q4-2023-adj-eps-060-misses-061-estimate-sales-61653m-beat-60709m-estimate

Globus Medical (NYSE:GMED) reported quarterly earnings of $0.60 per share which missed the analyst consensus estimate of $0.61 ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION